Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Delcath Systems (DCTH) Announces Proposed Common Share Offering
-
Delcath Systems Announces Proposed Public Offering of Common Stock
-
XPhyto Therapeutics Closes Investment
-
Net Asset Value(s)
-
Issue of Equity
-
Acceleration Partners Takes on Private Equity Investment to Fund Growth
-
CI Global Asset Management Files Final Prospectus for CI Galaxy Bitcoin Fund
-
NioBay Announces Closing of $11.6 M Brokered Private Placement
-
Amryt Announces $40m Private Placement with Leading Biotech Investors
-
Amryt Announces $40m Private Placement with Leading Biotech Investors
-
i3 Energy PLC Announces Appointment of Non-Executive Director
-
Docebo Announces Closing of Initial Public Offering in the United States and Public Offering in Canada
-
Momentus Inc. to Participate at the Canaccord NewSpace Virtual Investor Day
-
Digihost Announces Normal Course Issuer Bid
-
Digihost Announces Normal Course Issuer Bid
-
Northern Vertex Mining and Eclipse Gold Mining to Combine to Create New Western U.S. Gold Producer, Announce C$20 Million Financing
-
FuelCell Energy Announces Closing of Public Offering of 39,696,320 Shares of Common Stock
-
FuelCell Energy Announces Closing of Public Offering of 39,696,320 Shares of Common Stock
-
Sigilon Therapeutics (SGTX) IPO Opens 22% Higher
-
Ayr Strategies Announces $75 Million Senior Secured Debt Financing
-
Sigilon Therapeutics Inc. (SGTX) Prices 7M Share Upsized IPO at $18/Sh
-
Sigilon Therapeutics Announces Pricing of Upsized Initial Public Offering
-
Sigilon Therapeutics Announces Pricing of Upsized Initial Public Offering
-
Snowflake Inc. (SNOW) PT Raised to $275 at Canaccord Genuity, Following Earnings
-
Docebo Inc. (DCBO) Prices 3M Share Upsized IPO at $48/Sh; Prices Common Offering in Canada
-
Docebo Announces Pricing of Upsized Initial Public Offering in the United States and Public Offering in Canada
-
Laird Superfood to Participate in Canaccord and Roth Investor Conferences
-
Sun Life Financial names insider Strain CEO, succeeding Connor
-
MaxMyInterest Appoints Jill Denham to Advisory Board
-
ZoomInfo Technologies Inc. (ZI) Prices 12.5M Class A Share Common Offering at $45/Sh
-
QMX Gold Reports 53% Increase in Indicated Resources and 100% Increase in Inferred Resources at Bonnefond
-
ZoomInfo Announces Pricing of Secondary Offering of Shares of Class A Common Stock
-
Total voting rights
-
SEB Announces the Completion of $20 Million Strategic Financing and $10 Million New Credit Facility
-
Docebo Inc. (DCBO) Announces IPO in U.S. and Common Offering in Canada
-
Docebo Announces Initial Public Offering in the United States and Public Offering in Canada
-
Colson Capital Corp. and The Clinic Network Canada Inc. Announce Proposed Qualifying Transaction
-
Whole Earth Brands, Inc. to Participate in the Canaccord Genuity 2020 Virtual AgriFood Tech Innovation Summit
-
C3.ai Announces Launch of Initial Public Offering
-
Correction: IQE plc: Holding(s) in Company
-
IQE plc: Holding(s) in Company
-
Metallic Minerals Announces Closing on $3 Million in Oversubscribed Flow-Through Private Placement
-
Cardinal Takeover Offers Update
-
Stoke Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Paramit Corporation Expands Capabilities and Geographic Footprint with Acquisition of Emphysys, Inc.
-
Net Asset Value(s)
-
Subversive Capital Acquisition Corp., the Largest Cannabis SPAC in History, Announces Transaction with Shawn “JAY-Z” Carter, Roc Nation, Caliva and Left Coast Ventures
-
Cardinal Takeover Offers Update
-
Silver Elephant Announces Closing of C$9.2 Million Bought Deal Public Offering, Including Full Exercise of the Over-Allotment Option
-
Havn Life Sciences Announces $5.46 Million Warrant Exercise

